Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
life sciences
national blog main
akcea therapeutics
anylam pharmaceuticals
boston blog main
boston top stories
cannabidiol
cardiomyopathy
dravet syndrome
epidiolex
fda
fen-phen
fenfluramine
gw pharmaceuticals
inotersen
lennox-gastaut syndrome
national top stories
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
tafamidis
tegsedi
transthyretin amyloidosis
zogenix
What
ago
2
×
approved
2
×
battle
drug
fda
2
×
rare
2
×
sets
akcea
alnylam
amyloidosis
attr
available
cannabis
data
debilitating
derivative
disease
epilepsy
form
genetic
gw
gw’s
marijuana
market
medicine
medicines
oks
patients
pfizer
pharmaceuticals
transthyretin
weeks
year
zogenix
Language
Current search:
fda
×
approved
×
ago
×
rare
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
6 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug